Debra A. Pratt retweetledi

🥳 Exciting Update! @IceCureMedical Receives @FDA Marketing Authorization for ProSense® Cryoablation for the Treatment of Low-Risk Breast Cancer in Women Aged 70 and Above
❄️ ProSense® is the first and only medical device to be granted FDA marketing authorization for the local treatment of breast cancer
❄️Major advancement and new paradigm in breast cancer care as a simple, minimally invasive out-patient procedure
❄️Initial reimbursement under the CPT III code which covers $3,800 of facility costs, with additional reimbursement coverage expected
❄️U.S. sales and distribution team ready to drive sales of ProSense® systems and disposable probes—supporting medical community and patients looking for a new minimally invasive option to lumpectomy
❄️Enthusiastic response from top U.S. breast surgeons and radiologists
❄️Conference call to be held Monday, October 6 at 8:30AM Eastern Time
📖 Read the full press release for full details: ir.icecure-medical.com/news-events/pr…
@shamir_eyal @BussiTlalit
#investorrelastions @Nasdaq $ICCM

English





















